The constant conflicts of opioid prescribing - GPs' views on treating chronic pain with opioids in primary care: a reflexive qualitative analysis.
Anna Svensson, Hanna Ljungvall, Thomas Kempen...
https://pubmed.ncbi.nlm.nih.gov/42083502/Actively Recruiting
Led by Uppsala County Council, Sweden · Updated on 2026-09-30
110
Participants Needed
4
Research Sites
26 weeks
Total Duration
Researchers are evaluating a new person-centred and team-based approach to reduce inappropriate long-term opioid treatment LTOT and improve pain management for patients with chronic non-cancer pain in primary care. The study aims to compare this new approach to usual care, focusing on reducing pain interference. The background highlights concerns about opioid prescriptions in Swedish primary care and the need for better multi-professional interventions involving pharmacists and care managers. The person-centred team-based treatment includes three phases over 24 weeks Phase 1 weeks 1-3 involves medication review, pain assessment, and visits to a pharmacist, general practitioner, physiotherapist, psychologist, and care manager. Phase 2 weeks 3-4 consists of a team consultation with all healthcare personnel and the patient to create an individualized rehabilitation plan. Phase 3 weeks 4-24 implements the plan with frequent follow-ups by phone with the care manager and a second team consultation midway through. Participants will be actively involved for 12 months, including assessments of pain interference, pain intensity, depression, anxiety, patient satisfaction, quality of life, opioid use, and withdrawal symptoms at multiple time points. Follow-ups include phone contacts and team consultations. The study is conducted at healthcare centres with and without pharmacists, with special training for healthcare personnel in the intervention group. The primary outcome is pain interference after 6 months.
CONDITIONS
Improved Treatment for Patients With Long-term Opioid Therapy for Non-cancer Pain in Primary Care
M
Magnus Peterson, PhD, MD
A
Anna Svensson, MD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Uppsala County Council, Sweden
Lead Sponsor
Uppsala University
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Weeks 1 to 3
Participants undergo medication review, pain analysis, and visits with a pharmacist, general practitioner, physiotherapist, psychologist, and care manager to assess their pain and related conditions.
Multiple visits during weeks 1 to 3
Duration - Weeks 3 to 4
A team consultation including the patient and healthcare professionals is held to create an individualized rehabilitation plan.
1 team consultation visit
Duration - Weeks 4 to 24
Participants follow the individualized rehabilitation plan with frequent follow-up contacts by phone with a care manager and a second team consultation halfway through the treatment.
Phone contacts every 1 to 3 weeks and 1 team consultation
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Anna Svensson, Hanna Ljungvall, Thomas Kempen...
https://pubmed.ncbi.nlm.nih.gov/42083502/Uppsala County Council, Sweden
Lead Sponsor
Uppsala University
Collaborating Sponsor